MDxHealth to Present Third Quarter 2023 Financial Results and Corporate Update on November 8
NEWS RELEASE
25 OCTOBER 2023, 4PM ET / 22:00 CET
MDxHealth to Present Third Quarter 2023 Financial Results
and Corporate Update on November 8
Company to Host Conference Call with Live Q&A, November 8, 2023 at 4:30pm ET/ 22:30 CET
IRVINE, CA, and HERSTAL, BELGIUM – October 25, 2023 – MDxHealth SA (NASDAQ/Euronext: MDXH), a commercial-stage precision diagnostics company, today announced it will release its financial results for the third quarter and nine-month period ended September 30, 2023, after market close on Wednesday, November 8, 2023.
| Title: | MDxHealth Presents Third Quarter 2023 Financial Results and Corporate Update Conference Call and Webcast |
| Speakers: | Michael K. McGarrity, Chief Executive Officer Ron Kalfus, Chief Financial Officer |
| Date: | November 8, 2023 |
| Time: | 4:30pm ET/ 22:30 CET |
| Conference Call Dial-in Details: | United States: 1-888-886-7786 Belgium: 0800 76018 The Netherlands: 0800 022 7908 United Kingdom: 4480 065 22435 |
| Conference ID: | 00680078 |
| Webcast: | |
The webcast should be accessed 15 minutes prior to the conference call start time. A replay of the webcast will be available following the conclusion of the live call and will be accessible on the Company’s website.
About MDxHealth
mdxhealth is a commercial-stage precision diagnostics company that provides actionable molecular information to personalize patient diagnosis and treatment. The Company’s tests are based on proprietary genomic, epigenetic (methylation) and other molecular technologies and assist physicians with the diagnosis and prognosis of urologic cancers and other urologic diseases. The Company’s U.S. headquarters and laboratory operations are in Irvine, California, with additional laboratory operations in Plano, Texas. European headquarters are in Herstal, Belgium, with laboratory operations in Nijmegen, The Netherlands. For more information, visit and follow us on social media at: , and .
For more information:
| MDxHealth | |
| LifeSci Advisors (IR & PR) US: |
NOTE: The mdxhealth logo, mdxhealth, Confirm mdx, Select mdx, Resolve mdx, Genomic Prostate Score, GPS and Monitor mdx are trademarks or registered trademarks of MDxHealth SA. All other trademarks and service marks are the property of their respective owners.
Attachment
